1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. NATCO PHARMA LTD.
Natco Pharma Ltd.
NSE: NATCOPHARM | BSE: 524816
Mid-range Performer
In 2 Starfolio Baskets
Download real time
Iran War Impact
1015.90 -159.90 (-13.60%)
28.76% Gain from 52W Low
4.1M
NSE+BSE Volume
High volume+loss today

NSE 29 May, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
Margin Decline
Natco Pharma's Q4 EBITDA margin drops 28% points due to higher input costs and a weaker product mix See details

Natco Pharma - NATCOPHARM, 524816 corporate action history

Check all corporate actions such as stock splits, bonuses, dividends, mergers & acquisitions, rights issues & board meeting announcements for Natco Pharma